Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer
Gastric Cancer · 2026-01 · 29 (1) · 1-15
DOI: 10.1007/s10120-025-01675-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gastric Cancer, online erschienen am 31.10.2025. Verfasst von Ruofan Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Repub…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Helicobacter pylori ( H. pylori ) infection is a recognized risk factor for gastric cancer (GC), which is the leading cause of cancer-related deaths worldwide. As a Class I carcinogen, H. pylori plays a central role in the occurrence and development of GC. Recent studies have highlighted the critical role of metabolic reprogramming inthe gastric cancer, and H. pylori infection has been shown to significantly alter metabolic pathways in gastric cancer. This review explores the mechanisms by which H. pylori infection drives metabolic changes in GC, particularly in glycolysis, lipid metabolism, and amino acid metabolism. By altering these metabolisms, H. pylori enhances the survival, proliferation, and metastasis of tumor cells, and also promotes immune evasion. Therefore, understanding the ways in which H. pylori -induced metabolic reprogramming of GC cells is essential for identifying new therapeutic targets. By summarizing the latest research progress of these metabolic pathways, new strategies and directions can be provided for gastric cancer treatment. Graphical abstract H. pylori regulates glycolysis, amino acid, and lipid metabolism to facilitate the occurrence and development of gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Republic of China.
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250021, People's Republic of China.
- Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Republic of China. xuhongwei@sdfmu.edu.cn.
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250021, People's Republic of China. xuhongwei@sdfmu.edu.cn.
ORCID-Profile: Hongwei Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Cao, R., Zhou, F., Zhu, C., & Xu, H. (2026). Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer. Gastric Cancer, 29(1), 1-15. https://doi.org/10.1007/s10120-025-01675-x
Vancouver
Cao R, Zhou F, Zhu C, Xu H. Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer. Gastric Cancer. 2026;29(1):1-15. doi:10.1007/s10120-025-01675-x
BibTeX
@article{Cao2026,
author = {Cao, Ruofan and Zhou, Feifei and Zhu, Cuiyu and Xu, Hongwei},
title = {Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer},
journal = {Gastric Cancer},
year = {2026},
volume = {29},
number = {1},
pages = {1--15},
doi = {10.1007/s10120-025-01675-x}
}
EUVIMED